Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
Zevtera® (ceftobiprole medocaril) provides a significant advancement in treating serious bacterial infections, demonstrating high efficacy against both MRSA and MSSA in recent phase 3 clinical trials.
Infectious Diseases April 18th 2024
Cleveland Clinic Journal of Medicine
This “From the Editor” in the Cleveland Clinic Journal of Medicine offers a nuanced view of corticosteroid therapy, highlighting the balance between their significant therapeutic benefits and the risk of adverse effects in long-term use.
Endocrinology, Diabetes, Metabolism April 15th 2024
Infectious Disease Advisor
MySTIRisk’s AI-driven analysis offers a nuanced approach to identifying patients at heightened risk for STIs, providing a crucial tool in optimizing healthcare strategies and interventions in sexual health clinics.
Infectious Diseases March 25th 2024
In the battle against recurrent herpes simplex virus infections, chronic suppressive therapy emerges as a pivotal strategy, diminishing both the physical burden of outbreaks and the psychological weight of potential transmission.
Dermatology March 20th 2024
The New England Journal of Medicine
In a striking case of syphilitic pharyngitis, a patient’s rare oropharyngeal symptoms prompt a deeper dive into differential diagnoses, emphasizing the critical role of serology and biopsy in confirming syphilis, a common infection with uncommon presentations.
Infectious Diseases March 13th 2024
Epoch Health
This study underscores the importance of a nuanced approach when considering the RZV vaccine for patients with a history of ocular shingles, as it may increase the risk of recurrence. It calls for a balanced assessment of the vaccine’s benefits against potential risks in this specific patient population.
Allergy & Immunology March 6th 2024